The preclinical phase of rheumatoid arthritis: what is acknowledged and what needs to be assessed?

Arthritis Rheum. 2013 Sep;65(9):2219-32. doi: 10.1002/art.38013.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / diagnosis*
  • Arthritis, Rheumatoid / drug therapy
  • Arthritis, Rheumatoid / genetics
  • Humans
  • Prodromal Symptoms*
  • Risk Factors

Substances

  • Antirheumatic Agents